NL
Insider
Nicole LaBrosse
SVP, CHIEF FINANCIAL OFFICERNicole LaBrosse (SVP, CHIEF FINANCIAL OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $149K of HALO (1,913 sh × $77.83, as filed), executed Sep 22 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 22 2025
Filed Sep 23 2025
Median ADV $214.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
HALORecent filings
HALOSALE
Halozyme Therapeutics, Inc.
View filing →
$149K1,913 sh × $77.83
Exec Sep 22 2025
Filed Sep 23 2025 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $1.5M
20,000 sh across 2 lots
Exec Sep 10 2025
Filed Sep 11 2025 · 5:30 PM ET